Pressure BioSciences (PBIO) 10-Q2013 Q1 Quarterly report

Filed: 20 May 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: acid, animal, announced, appointed, attributable, Bayer, biopsy, Bioscience, Bruce, career, CEO, challenging, Chiron, conference, conjunction, conveniently, crucial, customary, defaulted, deoxyribonucleic, discretion, disease, ETH, fari, FDA, FFPE, Florida, focused, footnote, Forum, Foundation, founded, goal, growing, harnessing, heart, heat, highlighted, human, hydrostatic, important, inch, inherent, machine, mandatory, McCord, Melinda, membrane, Mickey, microbial, modification, needle, opportunity, psi, range, rape, recover, repaid, reproducibly, resale, reset, ribonucleic, RNA, safely, sequencing, solving, SPS, standard, stem, step, Stockholder, successful, team, thereunder, today, uncollateralized, Urdea, vitally, Warranst, wide, withdrawn, worldwide, Zurich

Removed: acquiring, adjusted, arise, assessed, attempt, aware, beneficially, bid, biology, biomarker, capability, circumvention, closed, coercive, collectively, commenced, commencement, confidence, continuation, core, critical, declared, deficiency, define, delisted, delisting, detected, deter, device, difficult, digestion, earning, effort, enabled, entry, execute, exempt, facilitate, failed, falling, finder, force, half, hereunder, histology, homogenization, impose, inclusion, initially, institutional, insufficient, intention, leverage, listed, lose, marketplace, mechanical, misstatement, offer, OTCQB, owe, owner, participated, PBIO, penny, periodic, planned, power, practice, prevent, prevented, proprietary, pursuing, qualifying, redeem, redeemed, reduce, referred, remediated, response, responsible, secondary, selection, soil, spectrometry, succeed, sufficiency, symbol, takeover, tender, threshold, ticker, unavailable, unfair, unsolicited, vested, void, voluntarily

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

PBIO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

In connection with the Quarterly Report on Form 10-Q of Pressure BioSciences, Inc., a Massachusetts corporation (the “Company”) for the period ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Conrad F. Mir Chief Financial Officer of the Company, do hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) that:

(1) The Report of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 20, 2013	By:	/s/ Conrad F. Mir
		Conrad F. Mir
		Chief Financial Officer (Principal Financial Officer)

A signed original of this written statement required by Section 906 has been provided to Pressure BioSciences, Inc. and will be retained by Pressure BioSciences, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.